Related Experiment Videos

Multicentric Castleman's disease: a challenging diagnosis

Györgyi Műzes1, Ferenc Sipos, Judit Csomor

  • 12nd Department of Medicine, Semmelweis University, 1088 Budapest, Szentkirályi u. 46., Hungary. muzes.gyorgyi@med.semmelweis-univ.hu

Pathology Oncology Research : POR
|March 22, 2013
PubMed

Insights

Multicentric Castleman's disease (MCD) is a systemic inflammatory disorder affecting multiple organs. Targeting key factors like IL-6 shows promise for future therapies.

Area of Science:

  • Immunology
  • Oncology
  • Pathology

Background:

  • Multicentric Castleman's disease (MCD) is a systemic inflammatory syndrome.
  • It presents with generalized lymphadenopathy and multiorgan involvement.
  • MCD has distinct histological variants and subtypes with varying prognoses.

Purpose of the Study:

  • To review the pathogenesis and clinical presentation of Multicentric Castleman's disease.
  • To highlight the role of Interleukin-6 (IL-6) in MCD.
  • To discuss potential therapeutic targets based on disease mechanisms.

Main Methods:

  • Literature review of Multicentric Castleman's disease.
  • Analysis of histological variants and subtypes.
  • Examination of the role of IL-6 and HHV-8 in MCD pathogenesis.

Main Results:

  • MCD is characterized by chronic inflammation, lymphadenopathy, and multiorgan involvement.
  • Two main histological variants exist: hyaline vascular and plasma cell.
  • Both idiopathic and HHV-8-driven MCD have poor prognoses, with IL-6 playing a central role.

Conclusions:

  • MCD is a complex systemic disorder with significant morbidity.
  • IL-6 is a critical factor in MCD pathogenesis, leading to its designation as IL-6 lymphadenopathy.
  • Identifying and targeting key regulatory factors, particularly IL-6, offers promising therapeutic avenues.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...